Glossary

Common terms and definitions for peptides and compounds

31 terms

Agonist

General Terms

A substance that binds to a receptor and activates it, producing a biological response. For example, GLP-1 agonists like Semaglutide bind to GLP-1 receptors to reduce appetite.

Related:

Amino Acid

General Terms

The building blocks of peptides and proteins. There are 20 standard amino acids that combine in different sequences to form peptides with specific functions.

Related:

Bacteriostatic Water (BAC Water)

Administration

Sterile water containing 0.9% benzyl alcohol, which prevents bacterial growth. Used to reconstitute peptides and allows the solution to be used over multiple doses. Different from sterile water, which should only be used once.

Related:

Bioavailability

General Terms

The percentage of a compound that reaches systemic circulation and is available to produce effects. Injectable peptides typically have near 100% bioavailability, while oral forms are often much lower due to digestive breakdown.

Related:

BPC (Body Protection Compound)

Compound Types

A peptide sequence originally isolated from human gastric juice. BPC-157 is a synthetic version known for accelerating tissue healing, reducing inflammation, and supporting gut health through multiple mechanisms.

Related:

Cycling

Protocols & Dosing

Alternating periods of using a compound with periods of rest. Cycling prevents receptor desensitization and maintains effectiveness. Common patterns include 5 days on / 2 days off, or 8 weeks on / 4 weeks off.

Related: ,

Fasted Administration

Protocols & Dosing

Taking a compound on an empty stomach, typically 2+ hours after eating. Many GH secretagogues work best when taken fasted, as food (especially carbs and fats) can blunt the GH response.

GH Secretagogue

Compound Types

A compound that stimulates the pituitary gland to release growth hormone (GH). These include GHRH analogs (like CJC-1295) and ghrelin mimetics (like Ipamorelin). They amplify your body's natural GH production rather than replacing it.

Related: , ,

GHRH (Growth Hormone Releasing Hormone)

Compound Types

A hormone produced by the hypothalamus that signals the pituitary to release growth hormone. Synthetic analogs like CJC-1295 and Sermorelin mimic GHRH to stimulate GH release.

Related: ,

GHRP (Growth Hormone Releasing Peptide)

Compound Types

A class of peptides that stimulate GH release by mimicking ghrelin and binding to the ghrelin receptor. Examples include Ipamorelin and GHRP-6. Often used in combination with GHRH analogs for synergistic effects.

Related: ,

GLP-1 (Glucagon-Like Peptide-1)

Compound Types

A hormone released by the gut after eating that reduces appetite, slows gastric emptying, and improves insulin sensitivity. GLP-1 agonists like Semaglutide and Tirzepatide are used for weight management and diabetes.

Related:

GLP-1 Agonist

Compound Types

Medications that mimic the GLP-1 hormone to reduce appetite and improve blood sugar control. Examples include Semaglutide (Ozempic/Wegovy), Tirzepatide (Mounjaro), and Retatrutide. Typically administered weekly.

Related:

Growth Hormone (GH / HGH)

Compound Types

A hormone produced by the pituitary gland that stimulates growth, cell reproduction, and regeneration. GH secretagogues stimulate natural GH production, while HGH therapy involves direct hormone replacement.

Related: ,

Half-Life

General Terms

The time it takes for half of a compound to be eliminated from your body. Short half-life peptides (like Ipamorelin) require more frequent dosing, while long half-life versions (like CJC-1295 with DAC) can be dosed weekly.

Related:

IGF-1 (Insulin-like Growth Factor 1)

Compound Types

A hormone produced primarily in the liver in response to growth hormone. IGF-1 mediates many of GH's anabolic effects on muscle, bone, and tissue. Blood IGF-1 levels are often used to assess GH status.

Related:

Insulin Syringe

Administration

A small syringe with a fine needle (typically 29-31 gauge) designed for subcutaneous injections. Commonly used for peptide administration due to accurate dosing markings and minimal discomfort.

Related:

Intramuscular (IM)

Administration

An injection method where the needle penetrates deeper into muscle tissue. Some compounds like Cerebrolysin and certain B12 preparations are administered intramuscularly for better absorption or to reduce injection site reactions.

Related: ,

Loading Phase

Protocols & Dosing

An initial period of higher or more frequent dosing to quickly build up tissue concentration. Some protocols for TB-500 and Melanotan use loading phases (e.g., 2 weeks of daily dosing) before transitioning to maintenance.

Related:

Lyophilized (Freeze-Dried)

Administration

A preservation method where peptides are frozen and then dried under vacuum. This creates a stable powder that can be stored longer than liquid solutions. Most peptides ship in lyophilized form.

Related:

Maintenance Dose

Protocols & Dosing

A lower, ongoing dose used after an initial loading phase to maintain benefits. For example, TB-500 might use 2.5mg twice weekly during loading, then 2.5mg weekly for maintenance.

Related:

NAD+ (Nicotinamide Adenine Dinucleotide)

Compound Types

A coenzyme essential for cellular energy production, DNA repair, and the function of sirtuins (longevity proteins). NAD+ levels decline with age, leading to interest in precursors like NMN and NR, or direct NAD+ supplementation.

Nootropic

Compound Types

A substance that enhances cognitive function, including memory, focus, creativity, or motivation. Peptide nootropics like Semax and Selank work by modulating neurotransmitters and supporting brain-derived neurotrophic factor (BDNF).

Peptide

General Terms

A short chain of amino acids (typically 2-50) linked by peptide bonds. Peptides act as signaling molecules in the body, triggering specific biological responses like tissue repair, hormone release, or immune modulation.

Related: ,

Pulsatile Dosing

Protocols & Dosing

Dosing a compound to mimic the body's natural patterns of hormone release. Growth hormone is naturally released in pulses, so many GH secretagogue protocols aim to enhance these natural pulses rather than maintain constant levels.

Receptor

General Terms

A protein on or inside cells that binds to specific molecules (like peptides) and triggers a biological response. Different peptides target different receptors to produce their effects.

Receptor Desensitization

Protocols & Dosing

A reduction in receptor responsiveness after prolonged exposure to an agonist. This is why cycling is recommended for some peptides - taking breaks allows receptors to regain sensitivity.

Related:

Reconstitution

Administration

The process of mixing lyophilized (freeze-dried) peptide powder with bacteriostatic water to create an injectable solution. Proper technique involves slowly adding water to the vial wall to avoid damaging the peptide.

Related: ,

Stacking

Protocols & Dosing

The practice of combining multiple peptides or compounds in a protocol to achieve synergistic effects. For example, stacking CJC-1295 with Ipamorelin creates a stronger GH response than either alone.

Related:

Subcutaneous (SubQ)

Administration

An injection method where the needle is inserted into the fatty tissue just beneath the skin, typically in the abdomen, thigh, or upper arm. Most peptides are administered via subcutaneous injection using insulin syringes.

Related: ,

TB-500 (Thymosin Beta-4)

Compound Types

A synthetic fragment of Thymosin Beta-4, a naturally occurring peptide involved in tissue repair and regeneration. Known for promoting flexibility, reducing inflammation, and accelerating wound healing.

Related:

Titration

Protocols & Dosing

The practice of gradually increasing dosage over time to find the optimal dose while minimizing side effects. Common with GLP-1 agonists like Semaglutide, which typically start at 0.25mg and increase every 4 weeks.